Crizanlizumab (Adakveo)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Crizanlizumab (Adakveo), covering 2025-01-08 to 2025-01-08. Get the full timeline:
Most recent: Clinical Trial Update: An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients [Phase 4]